Arsenic is a known human carcinogen,[@r1] although it's unclear how it causes cancer. Some studies have suggested that epigenetic modifications---specifically DNA methylation---may play a role in arsenic toxicity.[@r2] In this issue of *EHP*, investigators identify gene-specific DNA methylation targets in white blood cells in a large study of Bangladeshi adults.[@r3]

In addition to cancer, chronic exposure to arsenic in drinking water has been associated with an increased risk of cardiovascular disease, peripheral neuropathy, respiratory diseases, and diabetes.[@r4] Previous epidemiological studies probing DNA methylation and arsenic exposure have isolated methylation patterns within specific genes of interest,[@r5]^,^[@r6] and a few have begun to assess epigenome-wide changes.[@r7]^,^[@r8]^,^[@r9] The new study is the largest to date to investigate arsenic-related changes throughout the epigenome.
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"Many of the genes we identified happened to be related to pathways that are associated with skin cancer, which was very relevant to the study population," says lead author Maria Argos, an epidemiologist at the University of Illinois at Chicago. The researchers used blood and urine samples provided by more than 400 adults from rural Bangladesh with arsenical skin lesions---thickened or blackened areas of the skin that are associated with chronic arsenic exposure. People with arsenical skin lesions may be at an increased risk for developing skin cancer.[@r10]

Four gene loci showed significant changes in methylation status in relation to urinary arsenic concentration. Three of these also showed significant changes in relation to blood arsenic concentration. These four loci---sites in the genes *PLA2G2C*, *SQSTM1*, *SLC4A4*, and *IGH*---had not previously been associated with arsenic exposure.[@r3]

The researchers observed that several of the differentially methylated loci were associated with changes in gene expression levels in white blood cells.[@r3] "The changes in gene expression that we observed make sense in the arsenic pathology that we see. These are good clues for exploring mechanism and prevention avenues," says senior study author Habibul Ahsan, a medical epidemiologist at the University of Chicago.

For instance, *PLA2G2C* encodes lipid mediators with roles in inflammation, cell growth, and cell death,[@r11] making them potentially important for cancer progression.[@r3] Higher arsenic exposure was associated with decreased methylation levels at a locus of the *SQSTM1* gene that has been implicated in a number of diseases, including cancer, obesity, insulin resistance, and neurodegenerative diseases.[@r12]

"The addition of gene expression data to DNA methylation data makes this study very unique and begins to suggest how some of the epigenetic changes may be linked to downstream health outcomes," says Carmen Marsit, a molecular epidemiologist at the Geisel School of Medicine, Dartmouth College, who was not involved with the study.

The researchers identified methylation patterns in blood cells, but every tissue type in the body has a different methylation pattern. "We can't necessarily say that the DNA methylation profile associated with arsenic exposure in blood would be the same as in skin or other tissues of the body," Argos says.

The majority of study participants had higher levels of arsenic exposure than would typically be seen in the U.S. population, says Ahsan. And although skin lesions can develop at any level of arsenic exposure, he says, they are more widespread among people of South Asian descent, suggesting a genetic component. "It's not clear yet how important a factor genetic variation may be in setting DNA methylation patterns," Marsit says.

According to Argos, epidemiological studies may be able to use DNA methylation patterns in blood as a surrogate for past exposures to arsenic. Scientific research combining DNA methylation and gene expression data is a step toward doing more integrative molecular studies, she says. "We showed there is a lot to be learned by overlaying different types of molecular data."
